All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @demilwalker on TikTok · 89s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @demilwalker's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00I am Evan, and is em big baby.
  2. 0:02For those of you who don't know me, I'm Demi, I'm 29.
  3. 0:05I'm six months pregnant with baby number two.
  4. 0:07I've already got a son Tommy who's seven years old.
  5. 0:10We were trying to conceive for almost five years,
  6. 0:12and literally we tried everything in the book.
  7. 0:14We done natural remedies, natural cycles,
  8. 0:16ovulation tracking, thermometer tracking,
  9. 0:19you name it, we had tried it,
  10. 0:20and just nothing was working, okay?
  11. 0:22I have been diagnosed with PCOS,
  12. 0:24so obviously that's known to cause infertility and struggles,
  13. 0:27and it actually took nearly a year
  14. 0:29to conceive with Tommy.
  15. 0:30But obviously this time around,
  16. 0:32we are going into the five year mark.
  17. 0:33So last year's em big baby started trending on TikTok,
  18. 0:36it was all I kept seeing,
  19. 0:37and more doctors were basically saying was,
  20. 0:39estrogen gets stored in fat cells,
  21. 0:41and obviously when you are losing the fat,
  22. 0:43estrogen then releases into the body,
  23. 0:45this in turn makes you more photosis the female hormone,
  24. 0:48and people are falling pregnant.
  25. 0:49There were people who had been doing IVF for years,
  26. 0:51and using the female successful.
  27. 0:53Going on this medication and falling pregnant,
  28. 0:55there were also people who had PCOS,
  29. 0:57enter me to your says,
  30. 0:58going on this medication and falling pregnant.
  31. 1:01So I was like, right, I am definitely gonna do this,
  32. 1:03I totally get to my doctors,
  33. 1:04my own body, this is what I wanna do,
  34. 1:06I paid for it privately, and low on behold,
  35. 1:08so I went on the medication last March,
  36. 1:10and I come off it in the July,
  37. 1:12because we were born on holidays,
  38. 1:13and I wanted to be able to enjoy my food,
  39. 1:15and low on behold, within four weeks,
  40. 1:17I felt pregnant right at the beginning of August,
  41. 1:20with I would dream baby come true.
  42. 1:22All the time I was on the SMBEC,
  43. 1:23I didn't have no PCOS symptoms,
  44. 1:25I didn't have a single host or a doctor's visit, and yeah.
  45. 1:29Okay.

@demilwalker's Ozempic fertility claims need more context

DEMI WALKER

TikTok creator

662.6K viewsWatch on TikTok

Quick answer

Semaglutide improves hormonal and metabolic markers in women with PCOS, including insulin sensitivity and androgen levels, which can restore ovulatory function as a secondary effect of weight loss and direct GLP-1 receptor activity. However, semaglutide carries an FDA pregnancy category X designation, and clinical guidance recommends discontinuing it at least two months before attempting conception due to potential fetal risk. The creator's timeline, stopping in July and conceiving in August, falls within but at the edge of that recommended washout window.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @demilwalker's Ozempic fertility claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@demilwalker's Ozempic fertility claims need more context" from DEMI WALKER. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Semaglutide improves hormonal and metabolic markers in women with PCOS, including insulin sensitivity and androgen levels, which can restore ovulatory function as a secondary effect of weight loss and direct GLP-1 receptor activity.

The reason this review is not generic is the source wording and the canonical claim label "glp1 from hope to reality my ozempic baby journey last year." In this clip, the useful excerpt is: "I am Evan, and is em big baby." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Weight loss of 5-10% in women with PCOS improves ovulation rates significantly, per Lim et al.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Semaglutide improves hormonal and metabolic markers in women with PCOS, including insulin sensitivity and androgen levels, which can restore ovulatory function as a secondary effect of weight loss and direct GLP-1 receptor activity.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Semaglutide improves hormonal and metabolic markers in women with PCOS, including insulin sensitivity and androgen levels, which can restore ovulatory function as a secondary effect of weight loss and direct GLP-1 receptor activity. However, semaglutide carries an FDA pregnancy category X designation, and clinical guidance recommends discontinuing it at least two months before attempting conception due to potential fetal risk. The creator's timeline, stopping in July and conceiving in August, falls within but at the edge of that recommended washout window.
  • Semaglutide is not FDA-approved as a fertility treatment, and no randomized controlled trial has established it as one.
  • Weight loss of 5-10% in women with PCOS improves ovulation rates significantly, per Lim et al. (2019, Human Reproduction Update), and GLP-1 drugs can produce this loss.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • Semaglutide is not FDA-approved as a fertility treatment, and no randomized controlled trial has established it as one.
  • Weight loss of 5-10% in women with PCOS improves ovulation rates significantly, per Lim et al. (2019, Human Reproduction Update), and GLP-1 drugs can produce this loss.
  • Semaglutide carries an FDA pregnancy category X designation. Clinical guidelines recommend stopping it at least two months before trying to conceive.
  • GLP-1 medications may reduce the effectiveness of oral contraceptive pills by slowing gastric emptying and altering absorption, per Jensterle et al. (2019, Obesity Reviews), meaning unintended pregnancies are a real risk.
  • Saleh et al. (2023, Frontiers in Endocrinology) found improved menstrual regularity and androgen levels in PCOS patients on semaglutide, supporting biological plausibility but not a fertility protocol.
  • The creator's mechanism explanation, estrogen 'stored' in fat being released, is a simplified and somewhat inaccurate version of the actual aromatase-androgen pathway involved in PCOS and weight.
  • Anyone with PCOS considering GLP-1 therapy for weight management should discuss fertility implications with a reproductive endocrinologist before starting or stopping the medication.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @demilwalker actually say?

Demi, a 29-year-old with PCOS, says she struggled to conceive for nearly five years before starting semaglutide (Ozempic) privately in March. She stopped in July, and says she fell pregnant within four weeks of stopping. Her explanation for why it worked: "estrogen gets stored in fat cells," and when you lose fat, estrogen releases into the body, making you "more fertile." She also claims she had zero PCOS symptoms the entire time she was on the medication.

To be clear, she consulted her doctor, paid privately, and is not claiming Ozempic is a fertility drug. She is sharing a personal experience and offering a mechanism she heard on TikTok. Those are two very different things, and the distinction matters here.

Does the science back this up?

Partially, but the mechanism she describes is oversimplified and the evidence for semaglutide as a fertility aid is real but thin. The estrogen-fat cell explanation is not wrong exactly, but it leaves out most of the actual biology.

In people with PCOS and obesity, excess adipose tissue does convert androgens to estrone via aromatase, which disrupts the hormonal feedback loop that regulates ovulation. Weight loss, by any method, reduces that disruption. A 2019 meta-analysis by Lim et al. in Human Reproduction Update found that even modest weight loss of 5-10% in women with PCOS significantly improved ovulation rates and menstrual regularity. That is a real, documented effect. GLP-1 receptor agonists also appear to directly reduce androgen levels and improve insulin sensitivity in PCOS, independent of weight loss. Saleh et al. (2023, Frontiers in Endocrinology) reported improvements in menstrual cycle regularity and AMH levels in women with PCOS on semaglutide. So the broad claim, that this medication can improve fertility in people with PCOS, has biological plausibility and early clinical support. The specific estrogen-fat-cell framing Demi uses is TikTok-simplified, but it is not fabricated.

What did they get wrong (or right)?

The biggest problem here is the mechanism explanation. Saying estrogen "releases into the body" from fat cells and makes you "more fertile" skips over the actual pathway, which involves androgen-to-estrogen conversion, insulin resistance correction, and LH/FSH ratio normalization in PCOS. It sounds like a simple flush of estrogen, and that framing could mislead people into thinking more estrogen is always better, which it is not.

She also attributes her pregnancy entirely to Ozempic, which is unverifiable. She stopped the medication in July and conceived in August. It is entirely plausible that the weight loss and metabolic improvements from four months on semaglutide contributed to restored ovulation. It is also plausible that stopping the medication, and resuming normal eating, triggered an ovulatory rebound. We genuinely do not know which factor mattered most. There is no randomized controlled trial proving semaglutide causes pregnancy in PCOS patients. What she got right: she talked to her doctor, she did not present this as medical advice, and the biological basis for her story is not nonsense.

What should you actually know?

Semaglutide is not approved as a fertility treatment anywhere. It is classified as FDA Category X for pregnancy, meaning animal studies show fetal harm, and it should be discontinued at least two months before attempting conception. The fact that Demi stopped in July and conceived in August is actually closer to the recommended washout period, which is worth noting.

Women with PCOS who are considering semaglutide for weight management, and who may experience improved fertility as a side effect, need to be aware of this. Unintended pregnancies on GLP-1 medications have been reported, and the drug's interaction with oral contraceptives, by potentially altering absorption due to slowed gastric emptying, is a documented concern (Jensterle et al., 2019, Obesity Reviews).

  • Semaglutide is not a fertility drug and has not been approved or studied for that purpose in controlled trials.
  • Women on GLP-1 medications who do not want to become pregnant should use non-oral contraception or additional precautions.
  • Anyone who does want to conceive should discuss a structured stopping plan with their doctor well in advance.

Bottom line

Demi's story is biologically plausible, personally genuine, and responsibly framed as an anecdote. The TikTok mechanism she repeats is a simplified version of a real phenomenon. But 662,000 views means a lot of people are hearing this as a fertility protocol, and it is not one. Talk to a reproductive endocrinologist before treating a GLP-1 drug as an infertility solution.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

DEMI WALKER · TikTok creator

662.6K views on this video

From Hope to Reality: My Ozempic Baby Journey ✨ Last year, I stumbled across a TikTok trend about “Ozempic babies” — stories of women who had been struggling with infertility, IVF, PCOS, and endometr

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about semaglutide?

Semaglutide is not FDA-approved as a fertility treatment, and no randomized controlled trial has established it as one.

What does the video say about weight loss of 5-10% in women with pcos improves ovulation?

Weight loss of 5-10% in women with PCOS improves ovulation rates significantly, per Lim et al. (2019, Human Reproduction Update), and GLP-1 drugs can produce this loss.

What does the video say about semaglutide carries an fda pregnancy category x designation. clinical guidelines?

Semaglutide carries an FDA pregnancy category X designation. Clinical guidelines recommend stopping it at least two months before trying to conceive.

What does the video say about glp-1 medications may reduce the effectiveness of?

GLP-1 medications may reduce the effectiveness of oral contraceptive pills by slowing gastric emptying and altering absorption, per Jensterle et al. (2019, Obesity Reviews), meaning unintended pregnancies are a real risk.

What does the video say about saleh et al. (2023, frontiers in endocrinology) found improved menstrual?

Saleh et al. (2023, Frontiers in Endocrinology) found improved menstrual regularity and androgen levels in PCOS patients on semaglutide, supporting biological plausibility but not a fertility protocol.

What does the video say about the creator's mechanism explanation, estrogen 'stored' in fat being released,?

The creator's mechanism explanation, estrogen 'stored' in fat being released, is a simplified and somewhat inaccurate version of the actual aromatase-androgen pathway involved in PCOS and weight.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by DEMI WALKER, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.